Frank has a Bachelor of Science Degree in Immunology from the University of Glasgow and a PhD in Immunology and Microbiology from the University of Edinburgh. Frank currently holds the position of Head of Non-Clinical Safety, Immunology Portfolio, within Development Sciences at UCB Pharma, based in the UK. Frank has nearly 25 years experience in the immunology and safety assessment of biologics in academia (with nearly 70 publications in peer-reviewed journals), the CRO Industry (HLS), small biotechnology companies (Axis Genetics, Microscience), mid-size Pharma (Novo Nordisk, UCB) and large Pharma (AstraZeneca and Novartis). Frank has experience in designing, implementing and managing safety assessment programmes for a wide range of biotechnology classes, including monoclonal antibodies, therapeutic proteins, vaccines and adjuvants, gene and cell therapies and oligonucleotides, from early discovery to Life Cycle Management. Frank is a past Chair of the Biosafe Leadership Committee and currently sits on the Biosafe Executive Committee.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October